Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metreleptin in Anorexia Nervosa
NCT06305182Phase 2Recruiting
- Start
- May 2024
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of metreleptin in anorexia nervosa (AN). Started May 2024; status: recruiting.
02
Drugs
metreleptin
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT06305182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06305182.